Chronic obstructive pulmonary disease and smoking cessation

American Journal of Lifestyle Medicine

Volumn 6, Issue 2, 2012, Pages 159-166

  Parker, Donna R ^a,b   Eaton, Charles B ^a  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

chronic obstructive pulmonary disease; COPD; counseling; smoking cessation

Indexed keywords

EID: 84857664052     PISSN: 15598276     EISSN: 15598284     Source Type: Journal    
DOI: 10.1177/1559827611404872     Document Type: Review

References (44)

1. Lin K,Watkins B,Johnson T,Rodriguez JA,Barton MB.Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force.Ann Intern Med. 2008;148:535-543.
2. Mannino DM,Buist AS.Global burden of COPD: risk factors, prevalence, and future trends.Lancet. 2007;370:765-773.
3. Jemal A,Ward E,Hao Y, et al.Trends in the leading causes of death in the United States, 1970-2002.JAMA. 2005;294:1255-1259.
4. Leigh JP,Romano PS,Schenke MBR,Kreiss K.Costs of occupational COPD and asthma.Chest. 2002;121:264-272.
5. Raherison C,Girodet P.Epidemiology of COPD.Eur Respir Rev. 2009;18:213-221.
6. NIH-NHLBI. Morbidity and Mortality 2009 Chart Book on Cardiovascular, Lung and Blood Diseases. Bethesda, MD: US Department of Health and Human Services; 2009. http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdf.Accessed on January 22, 2010.
7. Silverman EK,Speizer FE.Risk factors for the development of chronic obstructive pulmonary disease.Med Clin North Am. 1996;80:501-522.
8. Scanlon PD,Connett JE,Waller LA,Altose MD,Bailey WC,Buist AS.Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study.Am J Respir Crit Care Med. 2000;161 (2, pt 1): 381-390.
9. Molfino NA.Genetics of COPD.Chest. 2004;125:1929-1940.
10. Gold Initiative for Chronic Obstructive pulmonary disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2009. http://www.goldcopd.com. Accessed November 20, 2010.
11. Laine C.In the clinic: smoking cessation, health consequences of smoking.Ann Int Med. 2007;146:.
12. Mannino DM.COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity.Chest. 2002;121 (5, suppl): 121S-126S.
13. Granda-Orive JI,Martinez-Albiach JM.Smoking cessation in patients with chronic obstructive pulmonary disease.Arch Bronconeumol. 2005;41:625-633.
14. Anthonisen NR,Connett JE,Kiley JP, et al.Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study.JAMA. 1994;272:1497-1505.
15. Anthonisen NR,Connett JE,Murray RP.Smoking and lung function of Lung Health Study participants after 11 years.Am J Respir Crit Care Med. 2002;166:675-679.
16. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services; 1990:90-8416.
17. Fagerstrom K.The epidemiology of smoking health consequences and benefits of smoking.Drugs. 2002;62 (suppl 2): 1-9.
18. Fiore C,Cohen W,Cohen S.A clinical practice guideline for treating tobacco use and dependence: a US public health service report. The Tobacco use consortium representatives.JAMA. 2000;283:3244-3254.
19. Wilson DH,Wakefield MA,Steven ID,Rohrsheim RA,Esterman AJ,Graham NM."Sick of Smoking": evaluation of a targeted minimal smoking cessation intervention in general practice.Med J Aust. 1990;152:518-521.
20. Fiore MC Jaen C Baker T. Treating tobacco use and dependence: 2008 update. http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf.Accessed November 22, 2010.
21. Motivational Interviewing: Preparing People to Change Addictive Behavior. Miller WRollnick S, ed. New York, NY: Guildord; 1991:.
22. Prochaska J,DiClemente C.Stages and processes of self-change of smoking: toward an integrative model of change.J Consult Clin Psychol. 1983;51:390-395.
23. Anderson JE,Jorenby DE,Scott WJ,Fiore MC.Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation.Chest. 2002;121:932-941.
24. Laniado-Laborin R.Smoking and chronic obstructive pulmonary disease (COPD): parallel epidemics of the 21 century.Int J Environ Res Public Health. 2009;6:209-224.
25. Zhu SH,Anderson CM,Tedeschi GJ, et al.Evidence of real-world effectiveness of a telephone quitline for smokers.N Engl J Med. 2002;347:1087-1093.
26. Morgan MD,Britton JR.Chronic obstructive pulmonary disease 8: non-pharmacological management of COPD.Thorax. 2003;58:453-457.
27. Mohanasundaram UM,Chitkara R,Krishna G.Smoking cessation therapy with varenicline.Int J Chron Obstruct Pulmon Dis. 2008;3:239-251.
28. Agency for Healthcare Research and Quality. Helping smokers quit: a guide for clinicians. http://www.ahrq.gov/clinic/tobacco/clinhlpsmksqt.htm.Accessed November 20, 2010.
29. US Public Health Service. Treating tobacco use and dependence: quick reference guide for clinicians. http://www.surgeongeneral.gov/tobacco/tobaqrg.htm. Accessed November 20, 2010.
30. Wu P,Wilson K,Dimoulas P,Mills EJ.Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.BMC Public Health. 2006;6:300.
31. van der Meer RM,Wagena EJ,Ostelo RW,Jacobs JE,van Schayck CP.Smoking cessation for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2003;2:CD002999.
32. Strassmann R,Bausch B,Spaar A,Kleijnen J,Braendli O,Puhan MA.Smoking cessation interventions in COPD: a network meta-analysis of randomised trials.Eur Respir J. 2009;34:634-640.
33. Pederson LL,Wanklin JM,Lefcoe NM.The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial.Int J Addict. 1991;26:107-119.
34. Anthonisen NR,Skeans MA,Wise RA,Manfreda J,Kanner RE,Connett JE.The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.Ann Intern Med. 2005;142:233-239.
35. Crowley TJ,Macdonald MJ,Walter MI.Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients.Psychopharmacology (Berl). 1995;119:193-204.
36. Brandt CJ,Ellegaard H,Joensen M,Kallan FV,Sorknaes AD,Tougaard L.Effect of diagnosis of "smoker's lung": RYLUNG Group.Lancet. 1997;349:253.
37. Tashkin D,Kanner R,Bailey W, et al.Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.Lancet. 2001;357:1571-1575.
38. Wagena EJ,Knipschild PG,Huibers MJ,Wouters EF,van Schayck CP.Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.Arch Intern Med. 2005;165:2286-2292.
39. Hilberink SR,Jacobs JE,Bottema BJ,de Vries H,Grol RP.Smoking cessation in patients with COPD in daily general practice (SMOCC): six months' results.Prev Med. 2005;41:822-827.
40. Tonnesen P,Mikkelsen K,Bremann L.Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support.Chest. 2006;130:334-342.
41. Silagy C,Lancaster T,Stead L,Mant D,Fowler G.Nicotine replacement therapy for smoking cessation.Cochrane Database Syst Rev. 2004;3:CD000146.
42. Hughes JR,Stead LF,Lancaster T.Antidepressants for smoking cessation.Cochrane Database Syst Rev. 2007;1:CD000031.
43. Cigarette smoking among adults: United States 2006.MMWR Morb Mortal Wkly Rep. 2007;56:1157-1161.
44. Wagena EJ,Kant I,van Amelsvoort LG,Wouters EF,van Schayck CP,Swaen GM.Risk of depression and anxiety in employees with chronic bronchitis: the modifying effect of cigarette smoking.Psychosom Med. 2004;66:729-734.